Skip to content
Clinical Research Made Simple

Clinical Research Made Simple

Trusted Resource for Clinical Trials, Protocols & Progress

Tag: comparisons

Regulatory Requirements for Group Comparisons – Clinical Trial Design and Protocol Development

Posted on June 12, 2025 digi By digi

Regulatory Requirements for Group Comparisons – Clinical Trial Design and Protocol Development “Rules and Regulations for Comparing Groups” Introduction Group comparisons in clinical studies are an essential aspect of pharmaceutical research and development. They enable researchers to measure the efficacy and safety of new drugs by comparing different groups of subjects. However, these comparisons must…

Read More “Regulatory Requirements for Group Comparisons – Clinical Trial Design and Protocol Development” »

Clinical Trial Design and Protocol Development, Parallel Group Designs

Quick Guide

  • Clinical Trial Phases
    • Preclinical Studies
    • Phase 0 (Microdosing Studies)
    • Phase 1 (Safety and Dosage)
    • Phase 2 (Efficacy and Side Effects)
    • Phase 3 (Confirmation and Monitoring)
    • Phase 4 (Post-Marketing Surveillance)
  • Regulatory Guidelines
    • U.S. FDA Regulations
    • CDSCO (India) Guidelines
    • EMA (European Medicines Agency) Guidelines
    • PMDA (Japan) Guidelines
    • MHRA (UK) Guidelines
    • TGA (Australia) Guidelines
    • Health Canada Guidelines
    • WHO Guidelines
    • ICH Guidelines
    • ASEAN Guidelines
  • Clinical Trial Design and Protocol Development
    • Randomized Controlled Trials (RCTs)
    • Adaptive Trial Designs
    • Crossover Trials
    • Parallel Group Designs
    • Factorial Designs
    • Cluster Randomized Trials
    • Single-Arm Trials
    • Open-Label Studies
    • Blinded Studies (Single, Double, Triple)
    • Non-Inferiority and Equivalence Trials
    • Randomization Techniques in Crossover Trials
  • Good Clinical Practice (GCP) and Compliance
    • GCP Training Programs
    • ICH-GCP Compliance
    • GCP Violations and Audit Responses
    • Monitoring Plans
    • Investigator Responsibilities
    • Sponsor Responsibilities
    • Ethics Committee Roles

Menu

Recent Posts

  • How to Prepare for GCP Inspections During Ongoing Phase 3 Trials: Compliance, Readiness, and Best Practices
  • Blinding and Randomization in Parallel Designs – Clinical Trial Design and Protocol Development
  • Regulatory Inspections and Audits in Phase 4 Trials: Preparation and Compliance
  • Regulatory Requirements for Group Comparisons – Clinical Trial Design and Protocol Development
  • Cardiac Safety in Phase 1: QTc and Intensive ECG Monitoring

Copyright © 2025 Clinical Research Made Simple.

Powered by PressBook WordPress theme